Despite lacking N-methyl-D-aspartate receptors, cerebellar Purkinje cells are highly vulnerable to ischaemic insults, which lead them to die necrotically in an a-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) receptor-dependent manner. To investigate the electrical events leading to this cell death, we whole-cell clamped Purkinje cells in cerebellar slices. Simulated ischaemia evoked an initial hyperpolarization of Purkinje cells by 8.5 mV, followed by a regenerative 'anoxic depolarization' (AD) to À14 mV. The AD was prevented by glutamate receptor blockers. In voltage-clamp mode, we used the cells' glutamate receptors to sense the rise of extracellular glutamate concentration induced by ischaemia, with GABA A and GABA B receptors blocked and Cs + as the main pipette cation. Ischaemia induced a small (<500 pA) slowly developing inward current in Purkinje cells, followed by a sudden large inward 'AD current' ($6 nA) which was largely prevented by blocking AMPA receptors. Removing extracellular calcium reduced the large glutamate-mediated current by $70% at early times (after 10 min ischaemia), but had no effect at later times (15 min). Blocking the operation of glutamate transporters, by preloading cells with the slowly transported glutamate analogue PDC (L-transpyrrolidine-2,4-dicarboxylate), reduced the current by $88% at early and 83% at later times. In Purkinje cells in slices from mice lacking the glial glutamate transporters GLAST or GLT-1, the ischaemia-evoked AD current was indistinguishable from that in wild-type slices. These data suggest that, in cerebellar ischaemia, the dominant cause of the electrophysiological dysfunction of Purkinje cells is an activation of Purkinje cell AMPA receptors. The glutamate activating these receptors is released both by exocytosis (at early times) and by reversal of a glutamate transporter, apparently in neurons.
Introduction
The cerebellum and hippocampus are particularly vulnerable to brain anoxia or ischaemia, showing loss of Purkinje cells and pyramidal cells, respectively (Pulsinelli, 1985; CervosNavarro and Diemer, 1991) . There have been numerous studies of the events evoked by hippocampal ischaemia, in which the cessation of ATP production inhibits the Na/K pump, generating a rise of extracellular potassium concentration (Hansen, 1985) . This leads to a release of glutamate by reversed uptake which activates N-methyl-D-aspartate (after $8 days post-natally) the NMDA receptors which usually mediate a large glutamate-evoked Ca 2+ influx into neurons (Yue et al., 1997; Martin et al., 2000) . Glutamate, acting at Purkinje cell AMPA receptors, must be involved because AMPA receptor blockers prevent ischaemia-evoked Purkinje cell death in vivo (Balchen and Diemer, 1992) . Since Purkinje cell AMPA receptors have a low Ca 2+ permeability (Tempia et al., 1996) , the [Ca 2+ ] i rise occurring in ischaemic Purkinje cells (Mitani et al., 1995) may be generated by voltage-gated Ca 2+ channels in response to the depolarization produced by incompletely desensitizing AMPA receptors (Brorson et al., 1995) .
In this study we provide the first detailed description of the electrophysiological response of cerebellar Purkinje neurons to ischaemia. We show that glutamate release is a key determinant of the cells' response to ischaemia and, by using the cells' glutamate receptors to sense the rise in extracellular glutamate concentration, we assess the source of the glutamate release which triggers Purkinje cell death.
Methods

Brain slices and extracellular solution
Sprague-Dawley rats or transgenic mice (see below), 12-19 days old, were killed by cervical dislocation in accordance with UK animal experimentation regulations. Patch-clamp recordings from visually identified Purkinje cells in thin (160-220 mm) parasagittal cerebellar slices were performed as previously described (Hamann et al., 2002a) . Slices were from animals of either sex. Recordings were made at 32 6 2 C. Normal extracellular solution contained (mM): NaCl 126, NaHCO 3 24, NaH 2 PO 4 1, KCl 2.5, CaCl 2 2.5, MgCl 2 2, D-glucose 10 (gassed with 95% O 2 /5% CO 2 ), pH 7.4. For experiments with no extracellular Ca 2+ , CaCl 2 was replaced by 2.5 mM MgCl 2 and 2 mM EGTA to chelate trace calcium. Kynurenic acid (1 mM) was included in the dissection and incubation solution (to block glutamate receptors, to reduce potential excitotoxic damage) but was omitted from the superfusion solution. To simulate the energy deprivation that occurs in ischaemia, glucose was replaced by 7 mM sucrose, 95% O 2 /5% CO 2 was replaced with 95% N 2 /5% CO 2 and 2 mM sodium iodoacetate and 1 mM sodium cyanide were added to block glycolysis and oxidative phosphorylation (Reiner et al., 1990) .
Preloading slices with PDC
To block reversed transport of glutamate, slices were preloaded with the slowly transported glutamate analogue L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC) (Longuemare and Swanson, 1995; Roettger and Lipton, 1996; Rossi et al., 2000) . Slices were soaked in PDC (1 mM) containing solution for 1 h, in the presence of 1 mM kynurenate to block glutamate receptors and prevent neuronal death. Control slices were soaked in 1 mM kynurenate alone. Roettger and Lipton (1996) have shown that this procedure accumulates PDC within the cells of hippocampal slices without leading to a loss of glutamate. Rossi et al. (2000) showed that it reduced the activity of glutamate transporters in hippocampal slices without affecting glutamate receptors (as we also show below for cerebellar slices).
Patch-clamp recording from cerebellar slices
For recording, slices were placed under flowing solution on the stage of an upright microscope and viewed with a ·40 or ·60 water immersion objective with differential interference contrast and infrared optics. Whole-cell voltage-clamp recordings were made using an Axopatch 200B amplifier (Axon Instruments, USA) from the somata of visually identified Purkinje neurons. Patch pipettes were constructed from thick-walled borosilicate glass capillaries. For current-clamp recordings of membrane potential and for voltageclamp experiments with E Cl set to À65 mV, the solution contained (mM) K-gluconate 120, KCl 7.7, NaCl 4, HEPES 10, BAPTA 10, MgATP 4 and Na 2 GTP 0.5, pH adjusted to 7.2 with KOH. For voltage-clamp recordings of membrane current with E Cl set to 0 mV they were filled with (mM) CsCl 130, NaCl 4, HEPES 10, BAPTA 10, MgATP 4, Na 2 GTP 0.5 and QX-314 10 (to block voltage-gated sodium currents and GABA B receptors), pH set to 7.2 with CsOH. Corrections for electrode junction potentials were made.
Series resistance voltage errors
In whole-cell mode, after series resistance compensation by $75%, the residual series resistance was $1 MV. The large size of the current changes evoked by ischaemia (up to 10 nA) at the peak of the anoxic depolarization (AD) means that, even after compensation, significant series resistance voltage errors (up to 10 mV) will inevitably occur (a detailed analysis of the effect of these errors for hippocampal pyramidal cells is presented in Hamann et al., 2002b) . Data are presented in this paper without correction for this, because the series resistance was similar in different experimental conditions, and correcting for series resistance voltage errors would not alter the conclusions reached.
Transgenic mice
The generation of mice lacking GLT-1 or GLAST, by disrupting the parts of the genes encoding the third transmembrane region of the GLT-1 protein, or the 4th transmembrane region of GLAST, and their genotyping, have been described in detail previously (Tanaka et al., 1997b; Watase et al., 1998) . Knock-out (À/À) and wild-type (+/+) mice were produced by breeding heterozygote (+/À) mice which had been backcrossed 6-9 times with C57 Black/6 mice. Experiments were on 2-week-old animals killed by cervical dislocation, and were carried out on pairs of +/+ and À/À animals from the same litter to reduce any variability that may occur between litters. Cerebellar slicing and electrophysiological recording in mice were as for rats.
Previous work has shown that Purkinje cells in mice lacking GLAST, the main glutamate transporter in the cerebellar molecular layer, showed anatomical and physiological properties broadly similar to those in wild-type littermates, apart from small changes of excitatory post-synaptic current (EPSC) properties (Marcaggi et al., 2003) and the persistence of multiple climbing fibre innervation to older ages in the knock-out (Watase et al., 1998) . The overall anatomy of the cerebellum, including its size and foliation, Purkinje cell dendrite arborization, the area of the granule cell layer and the density of granule cells, the structure of parallel and climbing fibre synapses, and the parallel fibre synapse density, have been shown by a combination of light and electron microscopy not to differ significantly in the wild-type and GLAST knock-out mice and, like in wild-type mice, the parallel fibre fast EPSC is mediated solely by AMPA receptors with no NMDA receptor component (Watase et al., 1998) . Western blotting of cerebellum from wild-type and knock-out mice has indicated that knocking out GLAST does not alter the total expression of the other cerebellar glutamate transporters GLT-1, EAAC1 and EAAT4 (Watase et al., 1998) . In mice lacking GLT-1, there is no appreciable change in mRNA level for GLAST, EAAT4 or EAAC1 (Tanaka et al., 1997b) , and no obvious change in cerebellar anatomy or Purkinje cell morphology at the light microscopic level (our observations).
Statistics
The effects of drugs (or transporter knock-out) on the ischaemic responses were assessed by comparing data from interleaved slices studied in the absence or presence of each drug (or transporter). Data are presented as mean 6 standard error of the mean and significance of changes was assessed with a two-tailed Student's t-test or x 2 -test as appropriate.
Results
The voltage response of Purkinje cells to ischaemia
Purkinje cells whole-cell clamped with electrodes containing a mock-physiological solution (K + as the main cation and E Cl set to À65 mV) had an input resistance at À70 mV of 135 6 33 MV (7 cells). When not voltage-clamped, they tended to fire action potentials spontaneously; the voltage response of cells to solution mimicking ischaemia was studied after spontaneous spiking in control solution had been terminated by the injection of hyperpolarizing current to bring the resting potential to $À75 to À80 mV (mean value À78.3 6 0.7 mV in four cells).
At the onset of simulated ischaemia, Purkinje cells initially hyperpolarized to $À87 mV (mean hyperpolarization after 1-2.5 min in ischaemic solution was 8.5 6 1.3 mV in four cells), but after $8 min (504 6 8 s) this was followed, after a short burst of action potentials, by a rapid prolonged depolarization to À14.3 6 1.6 mV (Fig. 1A , mean data are shown in Fig. 1C ). The initial hyperpolarization and subsequent prolonged depolarization are analogous to the voltage changes seen in ischaemic hippocampus, where the hyperpolarization may reflect an activation of Ca 2+ -and ATP-gated K + channels when [ATP] falls following metabolic inhibition (Yamamoto et al., 1997; Nowicky and Duchen, 1998) and the sudden and prolonged depolarization is termed the AD (Hansen, 1985) .
To test the involvement of glutamate release in this series of events, we repeated this experiment in the presence throughout of the glutamate receptor blockers NBQX (25 mM) and D-AP5 (50 mM). The NMDA receptor blocker D-AP5 was included to guard against the possibility that the Purkinje cell still expressed some NMDA receptors (although these are normally absent after $8 days post-natally: Llano et al., 1991; Rosenmund et al., 1992; Hausser and Roth, 1997) . In the presence of these blockers the Purkinje cell showed only the hyperpolarization to $À87 mV produced by ischaemia (12.3 6 1.5 mV, from a resting potential of À74.7 6 0.9 mV in three cells: Fig. 1B and C) with a subsequent very slow depolarization but no AD. The absence of the AD when ionotropic glutamate receptor blockers are present, in recordings lasting 20 min in ischaemia, demonstrates that the AD is produced by glutamate release, and that current generated by metabotropic glutamate receptors (Crepel et al., 1991; Vranesic et al., 1991; Glaum et al., 1992; Linden et al., 1994) is not involved in generating the AD. The possible mechanism of the ischaemiaevoked hyperpolarization remaining when glutamate receptors are blocked is considered in the Discussion.
Reversibility of the anoxic depolarization
To determine for how long glutamate needs to depolarize Purkinje cells, in order to produce irreversible damage, we carried out experiments in which the superfusion solution was switched back from ischaemia solution to normal solution either $1 min (67 6 6 s in 14 cells) or $2.5 min (147 6 10 s in 16 cells) after the AD (the timing of which was defined as the time of maximum rate of change of the potential), and observed whether the membrane potential was able to recover from the AD. Some cells recovered towards the normal resting potential, although they tended to show some instability of the resting potential even after this recovery ( Fig. 1D) , while others failed to show a significant recovery (Fig. 1E ).
When cells fail to recover it is sometimes difficult to be certain that the lack of recovery does not result from movement of the cell relative to the electrode when the slice swells after the AD, so we rejected all cells in which the apparent potential fell to 0 mV and the capacity transient produced by a voltage step indicated complete loss of the cell. Having rejected these lost cells, to quantify the degree of irreversible depolarization we defined 'recovered' cells as those which hyperpolarized to at least À50 mV after ischaemia, while 'no-recovery' cells were those that failed to hyperpolarize beyond À30 mV (there were no cells which adopted potentials between À30 and À50 mV). Membrane potential recovery was greater when switching back to normal solution 1 min after the AD (10 out of 14 cells recovered) than when switching 2.5 min after the AD (4 out of 16 cells recovered), and this difference was significant (P = 0.03 by a x 2 -test with Yates correction; Fig. 1F ).
These data suggest that when glutamate is released and produces the AD it evokes irreversible damage to the cell in the first few minutes after the AD.
The current response of Purkinje cells to ischaemia
To study the mechanism of glutamate release, we voltageclamped Purkinje cells, and used their glutamate receptors to sense the rise of glutamate occurring. Figure 1G On applying ischaemic solution the current at À40 mV initially became more outward, reflecting the initial hyperpolarization seen in Fig. 1A , but then a large inward current suddenly developed, reflecting the AD in Fig. 1A . Applying NBQX and D-AP5 during the plateau of this current led to an almost complete block of the current (81 6 3% in five cells, calculated assuming a current baseline at the level of the outward current before the AD), demonstrating that the depolarizing current is generated largely by glutamate release activating ionotropic receptors (Fig. 1H) .
Having established that glutamate is the main agent producing the AD, subsequent experiments to define the receptor types generating the AD and to investigate the mechanism of glutamate release were performed in the presence of bicuculline (40 mM) plus picrotoxin (100 mM), to block GABA A receptor-mediated currents and thus help to isolate glutamate-mediated currents. In addition, Cs + was used as the main intracellular cation and QX-314 was included in the patch pipette (see Methods) to improve voltage uniformity in the Purkinje cell dendritic tree and to block GABA B receptors. Figure 2A shows a specimen current response to ischaemia solution recorded at À33 mV. When Cs + replaced K + as the main internal cation and GABA A receptors were blocked, the initial ischaemia-evoked outward current was absent and was replaced by a slowly developing inward current which may partly reflect K + entry through K + channels activated in ischaemia. After $8 min, 55 of the 56 cells studied showed an AD current that rapidly reached a peak and then decayed slowly ( Fig. 2A) , and sometimes increased again after that Specimen response to ischaemia of limited duration of a Purkinje cell which recovered its resting potential after the ischaemia. (E) Specimen response to ischaemia of limited duration of a Purkinje cell which failed to recover its resting potential after the ischaemia. (F) Number of cells recovering a resting potential more negative than À50 mV or failing to recover more negative than À30 mV, after termination of ischaemia 1 or 2.5 min after the AD. (G) Current response to ischaemia at À40 mV shows an outward current followed by a large inward current which declines to a smaller plateau. (H) Applying ionotropic glutamate receptor blockers greatly reduces the inward current. All records from cells studied with K-gluconate based internal solution.
(e.g. Figs 3C and 4C) . The time to the AD did not differ significantly (P = 0.44, Fig. 2B ) when voltage-clamping with Cs + in the pipette as in Fig. 2A , or recording in physiological conditions with K + in the pipette and the membrane potential unclamped as in Fig. 1A . When ischaemia solution containing NBQX and D-AP5 was applied, no AD current was seen in 5 out of 7 cells (Fig. 2C, cf. Fig. 1B ) while the remaining 2 out of 7 cells showed a smaller and more transient AD current than normal: overall the peak inward current generated was only 7.5% of that seen in 4 interleaved cells and 5% of that seen in all 56 cells studied (Fig. 2D) .
The AD is generated largely by AMPA receptors Purkinje cells lack NMDA receptors after $8 days post-natally (Llano et al., 1991; Rosenmund et al., 1992; Hausser and Roth, 1997) , but NMDA receptors on granule cells might contribute to controlling the release of glutamate onto Purkinje cells in ischaemia. However, applying D-AP5 to block the effects of glutamate on NMDA receptors after the AD had no effect on the ischaemia-evoked AD current (Fig. 3A, B and E). Superfusing the AMPA/kainate receptor blocker NBQX, either on top of D-AP5 (Fig. 3B) or alone (Fig. 3C ) resulted in most of the post-AD inward current being blocked.
To distinguish the possible contributions of AMPA-and kainate-receptors to the maintained depolarization produced by ischaemia, we studied the effect of the AMPA receptor blocker GYKI 53655 [20 mM, which blocks AMPA receptors by >90% but blocks kainate receptors by <5% (Wilding and Huettner, 1995; Bleakman et al., 1997) ]. GYKI 53655 blocked most of the ischaemia-evoked inward current after the AD ( Fig. 3D and E) and superimposing NBQX produced only a small further block, some of which may be block of the small fraction of AMPA receptors remaining unblocked by the GYKI 53655. On average GYKI 53655 blocked $80% of the total current blockable by GYKI 53655 and NBQX together (Fig. 3F) . Thus, the great majority of the ischaemia-evoked, glutamate-mediated current in Purkinje cells is mediated by AMPA receptors which do not completely desensitize in the maintained presence of glutamate.
Glutamate release is action potential independent
The occurrence of ischaemia-evoked action potentials in cells that are not voltage-clamped (Fig. 1A) suggested that the AD and glutamate release may be triggered by action potentials. To test this we applied ischaemic solution containing 1 mM TTX to block voltage-gated Na + channels (Fig. 3G) . TTX had no effect on the time to the AD, the magnitude of the AD current, or the current suppressed by ionotropic glutamate receptor blockers after the AD (I glu ) (Fig. 3H ).
Glutamate release is initially calcium-dependent
When ischaemia solution lacking calcium (and containing 2 mM EGTA to chelate trace Ca 2+ : see Methods) was applied ( Fig. 4B and D) , although an AD current was present at the normal latency (Fig. 4E) , it was smaller in amplitude (P < 0.01) than in interleaved slices in the control solution (Fig. 4A, C  and F) . Applying glutamate receptor blockers 10 min after the start of ischaemia suppressed a glutamate-mediated current that was only 30% of the amplitude seen in normal calciumcontaining solution (Fig. 4A , B and G, P = 0.016 compared with control solution). However, by 15 min after the start of ischaemia, the ischaemia-evoked inward current in zerocalcium solution had become much larger (Fig. 4D) , and the glutamate-mediated current was not significantly different from that seen after 15 min in normal solution ( Fig. 4C and H, P = 0.36). The response of Purkinje cells to superfused AMPA (1 mM, in 40 mM bicuculline, 50 mM D-AP5 and 1 mM TTX) was not affected by calcium removal (Fig. 4I and J) . Consequently, the suppression of ischaemia-induced currents produced by removing calcium (Fig. 4A-D -dependent. This is a reasonable assumption (which is supported by the reduction of glutamate release seen in Fig. 4) ; although it has been suggested that early ischaemia-evoked spontaneous exocytosis of transmitter is Ca 2+ -independent (Katchman and Hershkowitz, 1993; Fleidervish et al., 2001) , these studies did not use EGTA to chelate trace Ca
2+
, and subsequent work has suggested that this protocol did not lower [Ca 2+ ] o sufficiently to block Ca 2+ -dependent exocytosis .
Glutamate release is partly by reversed uptake
The run-down of ion gradients occurring during hippocampal ischaemia has been shown to lead to release of glutamate by reversal of glutamate transporters (Madl and Burgesser 1993; Roettger and Lipton, 1996; Phillis et al., 2000; Rossi et al., 2000) . A similar run-down of gradients occurs in ischaemic cerebellum, with [K + ] o rising to 40 mM (Kraig et al., 1983 Longuemare and Swanson (1995) , Roettger and Lipton (1996) and Rossi et al. (2000) to block transporter function. We preloaded slices with the slowly transported glutamate analogue PDC (see Methods), and then washed extracellular PDC out of the slice. The aim was to accumulate PDC intracellularly, so that if the run-down of ion gradients in ischaemia reverses the operation of glutamate transporters, the slowly transported PDC will bind preferentially, occupying the transporter and preventing glutamate release.
To assess whether this procedure succeeded in blocking transporter function, we compared the response of Purkinje cells in non-ischaemic slices to superfused glutamate (100 mM), the extracellular concentration of which is normally reduced by uptake, and to the non-transported glutamate analogue AMPA (1 mM). If PDC preloading blocks transporters then superfused glutamate should penetrate further into the slice and generate a larger response, relative to the response produced by AMPA which should be unaffected by block of uptake. Figure 5A and B show responses to glutamate and AMPA in a control slice and a slice preloaded with PDC. While the responses to AMPA were similar in control conditions and after PDC preloading (Fig. 5C ), the ratio of (response to glutamate)/(response to AMPA) was significantly greater (P = 0.04) in six slices preloaded with PDC than in five control slices (Fig. 5C) , confirming that the activity of transporters was reduced by the preloading procedure. Figure 5D shows the response to ischaemia of two PDCpreloaded slices, with NBQX and D-AP5 applied at $10 and $15 min after the AD (cf. the control data in Fig. 4A and C) . The PDC-preloaded slices show no AD current and a much smaller glutamate-mediated current. Out of 12 PDC preloaded slices studied, 7 showed complete abolition of the AD current (while only 1 out of 35 interleaved control slices failed to show an AD current; significantly different, P = 7 · 10 À5 by x 2 -test; Fig. 4E ). The remainder did show an AD current (presumably the PDC preloading was less successful in blocking reversed uptake, possibly because some PDC was lost from the cells during the time needed to locate and record from a cell), but the subsequent glutamatemediated current was reduced by 60-80% in magnitude.
Averaging over all the slices, PDC-preloading reduced the glutamate-mediated current measured 10 and 15 min after the start of ischaemia by 88 and 83%, respectively (Fig. 4E) .
These data, together with those recorded in 0 Ca 2+ solution, suggest that in the first 10 min of ischaemia glutamate is released both by exocytosis and by the reversed operation of glutamate transporters, but that by 15 min in ischaemia exocytotic glutamate release has stopped and the remaining release is almost entirely by reversed uptake.
GLAST and GLT-1 glutamate transporters do not release glutamate in ischaemia
Glutamate released by reversed uptake could in principle be released by GLAST and GLT-1, which are located in Bergmann glia and molecular layer astrocytes, or by the neuronal transporters EAAC1 and EAAT4, which are located in Purkinje cells (Chaudhry et al., 1995; Yamada et al., 1996; Furuta et al., 1997a, b; Nagao et al., 1997) . In the cerebellar cortex the density of glial transporters [21 000/mm 3 for GLAST + GLT-1; Lehre and Danbolt (1998) ] is higher than that of neuronal transporters [21000/mm 3 for EAAT4, and EAAC1 is present at a lower level: Dehnes et al. (1998) ], but glial cells have a lower intracellular concentration of glutamate because of conversion to glutamine by glial glutamine synthetase, and so glial transporters may be less prone to reverse during the change of ionic gradients occurring in ischaemia. To investigate the possible role of glial transporters in releasing glutamate we used transgenic mice lacking either the GLAST or GLT-1 transporters, neither of which shows any major upregulation of other transporters (Tanaka et al., 1997b; Watase et al., 1998) .
The response to ischaemia of Purkinje cells in wild-type littermates of the GLT-1 and GLAST knock-out mice was similar to that in rats ( Fig. 6A and D) , except that the AD current occurred earlier than in rat Purkinje cells [after 235 6 15 s (n = 16) in wild-type controls for GLT-1 knockout mice, and 209 6 14 s (n = 14) in wild-type controls for GLAST knock-out mice, compared with 454 6 17 s in 55 rat Purkinje cells]. The subsequently maintained inward current was blocked by 25 mM NBQX and 50 mM D-AP5. As in rat Purkinje cells, PDC preloading greatly reduced the ischaemia-evoked glutamate-mediated current (measured after 10 min ischaemia), to 5.3% of its control value in wild-type littermates of GLT-1 KO mice (4 cells for PDC preloading, I glu = 110 6 41 pA, compared with 18 cells without preloading, I glu = 2061 6 242 pA, P = 0.0013; data not shown) and to 10.6% of its control value in littermates of GLAST KO mice (3 cells for PDC preloading, I glu = 248 6 100 pA, compared with 14 cells without preloading, I glu = 2335 6 392 pA, P = 0.03; data not shown). Thus, as for rat Purkinje cells, the ischaemia-evoked glutamate-mediated current is generated to a large extent by the reversal of glutamate transporters.
The response to ischaemia of GLT-1 knock-out and GLAST knock-out mice was indistinguishable from that in wild-type littermates ( Fig. 6B and E) , with no differences in the time to the AD current, the amplitude of the AD current or the magnitude of the glutamate-mediated current suppressed by NBQX and D-AP5 after the AD (Fig. 6C and F) .
These data suggest that, as in the hippocampus (Hamann et al., 2002b) , glial glutamate transporters do not contribute significantly to releasing glutamate early in severe cerebellar ischaemia, and thus that the release blockable by PDC preloading is via reversed operation of neuronal glutamate transporters, presumably EAAT4 and/or EAAC1.
Discussion
We have characterized for the first time the early electrical responses of cerebellar Purkinje cells to ischaemia, with the aim of understanding the mechanism of the ischaemia-evoked rise of extracellular glutamate concentration which leads to Purkinje cell death and motor dysfunction (Balchen and Diemer, 1992) .
Ischaemia initially hyperpolarizes Purkinje cells
When the cerebellum is made ischaemic, the loss of the ATP supply leads to the Na + /K + pump being inhibited and, as a result of the lack of pumping back into the cell of K + which leaks out because the membrane potential is more positive than E K (Rossi et al., 2000) , there is an initial slow rise of extracellular potassium concentration, [K + ] o , to $12 mM, followed by a more rapid rise to $40 mM (Kraig et al., 1983) . We find that Purkinje cells initially hyperpolarize when exposed to ischaemic solution. Whole-cell voltage-clamping the cells using a K-gluconate based pipette solution revealed an outward current corresponding to the initial hyperpolarization (Fig. 1G) . This was absent when using a CsClbased internal solution and GABA A receptors were blocked (Fig. 2) . The hyperpolarization cannot be produced by ischaemia-evoked GABA release activating GABA A receptors because the initial resting potential (À78 mV) was more negative than E Cl (À65 mV). It may, therefore, reflect the activation of a Ca 2+ -or ATP-gated K + current in Purkinje cells, as seen previously in hippocampal neurons (Nowicky and Duchen, 1998) , which could contribute to the initial rise of [K + ] o to $12 mM (Kraig et al., 1983) .
The AD of Purkinje cells is generated by glutamate and rapidly causes irrevocable malfunction
After the initial hyperpolarizing phase of the response to ischaemia, Purkinje cells exhibit a large and rapid AD which probably correlates with the rise of [K + ] o to $40 mM (Kraig et al., 1983) . The Purkinje cell AD was blocked by glutamate receptor blockers, and so reflects ischaemia-evoked glutamate release. By using blockers of NMDA, AMPA and AMPAplus-kainate receptors, we have shown that the great majority of the glutamate-mediated current is generated by AMPA receptors (Fig. 3A-F) . The rapid speed of the AD suggests that it is a regenerative event produced by a positive feedback loop like that in the hippocampus, where ionic gradient rundown releases K + which depolarizes cells and thus releases glutamate, which in turn depolarizes cells further and releases more K + . Recovery of the resting membrane potential after termination of simulated ischemia was prevented if the ischaemia was maintained for even just a few minutes after the AD occurred (Fig. 1D-F) .
The complete abolition of the AD that we see with glutamate receptors blocked is similar to the effect of receptor blockers in abolishing the AD in hippocampal pyramidal cells (Rossi et al., 2000) . The different types of glutamate receptors expressed in different brain areas will determine which receptor blockers are most effective at preventing the AD. In hippocampal pyramidal cells, where both NMDA and (to a lesser extent) AMPA receptors generate the ischaemia-evoked inward current (Rossi et al., 2000) , it is essential to have both receptor types strongly blocked to prevent the AD; blocking only one type delays, but does not prevent, the AD (Tanaka et al., 1997a) . Interestingly, some authors report an AD occurring even with blockers of both receptors present (Lauritzen and Hansen, 1992; Muller and Somjen, 2000) but in some cases at least (Jarvis et al., 2001 ) the blocker concentrations used were lower than those Rossi et al. (2000) found necessary to block the AD in the hippocampus: the positive feedback mechanisms involved in generating the AD require that a strong block of all glutamate receptors is achieved to prevent the AD. In the neocortex, blocking NMDA receptors alone is sufficient to block spreading depression (which has some similarities to the AD) and AMPA receptor block is ineffective (Nellgard and Wieloch, 1992) , probably because of the fairly complete desensitization of AMPA receptors in the face of a maintained glutamate concentration rise. In contrast, in cerebellar Purkinje cells, which lack NMDA receptors but have incompletely desensitizing AMPA receptors (Brorson et al., 1995) , it is essential to block AMPA receptors to prevent the AD (Fig. 3) .
Incompletely desensitizing AMPA receptors generate the AD Rossi et al. (2000) used a simple model of the ischaemic hippocampus to predict the rise of [K + ] o , membrane depolarization and rise of extracellular glutamate concentration produced by ischaemia, based on the idea that cutting off the ATP supply to the Na + /K + pump leads to run-down of the transmembrane ionic gradients, reversal of glutamate transporters and activation of glutamate receptors. In that simulation, activation of NMDA receptors by glutamate played a key role in producing a sustained depolarization of cells, because hippocampal AMPA receptors desensitize almost completely (Spruston et al., 1995) . Cerebellar Purkinje cells, by contrast, lack NMDA receptors after postnatal day 8, so the fact that ischaemia-evoked glutamate release generates a sustained depolarizing current (as in Figs 1-3 ) depends on Purkinje cell AMPA receptors desensitizing incompletely, as suggested by Brorson et al. (1995) .
Glutamate is released both by exocytosis and by reversal of glutamate transporters
In hippocampal slices, blocking glutamate release by reversed uptake can completely abolish the AD and subsequent glutamate release, whereas removing extracellular Ca 2+ has little effect (Rossi et al., 2000) . However, in cerebellar slices reversed uptake is not the only significant means of glutamate release. Blocking Ca 2+ -dependent exocytosis by removing extracellular Ca 2+ reduces glutamate release and thus reduces the glutamate-mediated membrane current by $70% early after the AD (10 min after the start of ischaemia; Fig. 4 ). Later than 15 min after the start of ischaemia, however, removing extracellular Ca 2+ has no effect on the ischaemiaevoked glutamate release. This situation is similar to that in striatum, where microdialysis experiments in vivo have shown that in ischaemia there is a brief period of Ca 2+ -dependent glutamate release, after which glutamate release is Ca 2+ -independent (Wahl et al., 1994) . Even with exocytosis blocked there is still substantial glutamate release in cerebellar ischaemia (Fig. 4) . Blocking reversed uptake by preloading with PDC produces a larger reduction of early (10 min) ischaemic glutamate release than does blocking exocytosis (Fig. 5) . Further, blocking reversed uptake produces a similar reduction of late glutamate release
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Brain (2005), 128, 2408-2420(15 min after the start of ischaemia; Fig. 4 ), but late glutamate release is unaffected by removing calcium (Fig. 5) . Thus, the major fraction of ischaemic glutamate release is by reversed uptake. Interestingly, after 10 min ischaemia, removal of calcium blocks $70% of the glutamate-mediated current, whereas blocking reversed uptake blocks $88%, implying (since the sum of these blocks is >100%) that these two release mechanisms do not have independent effects on the glutamate-mediated current. This could result simply from non-linearity in the conversion of extracellular glutamate concentration to AMPA receptor-mediated current. Alternatively, it could result from a synergy between the effects of release by Ca
2+
-dependent exocytosis and reversed uptake, as follows. Glutamate released by exocytosis will activate AMPA receptors and promote uptake reversal by raising [Na + ] i and depolarizing cells, and in addition the resulting ATP consumption on ion pumping (Attwell and Laughlin, 2001) will accelerate the run-down of ion gradients that reverses transporters. Thus, blocking exocytosis will reduce reversed uptake as well. Conversely, glutamate released by reversed uptake will depolarize cells and release more glutamate by exocytosis, so that blocking reversed uptake will reduce exocytotic glutamate release as well.
Glial glutamate transporters do not contribute to ischaemic glutamate release
Purkinje cells in knock-out mice lacking the glial transporters GLT-1 or GLAST showed electrophysiological responses to ischaemia that were indistinguishable from those in wild-type littermates, with a large AD current and large glutamate-mediated membrane current. This suggests that the ischaemia-evoked transporter-mediated release of glutamate occurs by reversal of pre-or post-synaptic neuronal glutamate transporters. Neuronal transporters are thermodynamically more likely to reverse in the altered ionic conditions of ischaemia than are glial-transporters, because the glutamate concentration is initially lower in glia, as a result of glutamate being converted to glutamine by the glial specific enzyme glutamine synthetase. Welsh et al. (2002) found that lesioning the climbing fibres reduced ischaemia-evoked Purkinje cell death in vivo, but it is unclear whether this reflects an abolition of glutamate release by reversed uptake in pre-synaptic terminals during ischaemia, or an abolition of exocytotic release after the ischaemic episode, since glutamate release after an ischaemic episode contributes to cell death in the hippocampus (Hammond et al., 1994; Szatkowski, 1994) . Interestingly, Welsh et al. (2002) also found that Purkinje cell death was inversely correlated with the expression of postsynaptic EAAT4 and the glycolytic enzyme aldolase, occurring preferentially in areas where EAAT4 and aldolase were at a low level. Although the increased death in areas of low EAAT4/aldolase might simply reflect less ATP production via aldolase, EAAT4 could also have a protective effect by lowering the glutamate concentration produced by exocytotic release of glutamate from the climbing fibres after a period of ischaemia (Otis et al., 1997; Auger and Attwell, 2000; Welsh et al., 2002) .
If neuronal glutamate transporters reverse and release glutamate in ischaemia, then why do glial transporters not take up glutamate and reduce the rise of extracellular glutamate concentration produced? For GLAST and GLT-1 to take up a substantial amount of glutamate, there may need to be continuous conversion of glutamate to glutamine within astrocytes. This process requires ATP, which is absent during ischaemia, so the intracellular concentration of glutamate in astrocytes rises at the start of ischaemia (Storm-Mathisen et al., 1992) when only a small amount of glutamate has been taken up. This will bring the driving force on the transporter closer to equilibrium and reduce further uptake of glutamate. A similar situation may occur in the hippocampus, where block or knock-out of GLT-1 transporters does not affect the time to the AD or the glutamate-mediated current after the AD (Rossi et al., 2000; Hamann et al., 2002b) , but knock-out of the neuronal glutamate transporter EAAC1 prolongs the time to the AD 3-fold (Gebhardt et al., 2002b) .
In summary, our data suggest that the glutamate release which triggers Purkinje cell death and motor dysfunction in ischaemia occurs both by exocytosis and by the reversal of neuronal glutamate transporters, and that this depolarizes Purkinje cells by acting on incompletely desensitizing AMPA receptors.
